Overview
Lobbying Costs
51,462€
Financial year: Jan 2015 - Jan 2016
Lobbyists (Full time equivalent)
2.25 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
LEO Pharma A/S (LEO Pharma)
EU Transparency Register
10184967810-77 First registered on 23 Jan 2012
Goals / Remit
Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company.
LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs.
LEO Pharma has its own sales forces in 61 countries and employs around 4,800 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation.
LEO Pharma’s revenue in 2013 amounted to DKK 7,842 million. The revenue decreased by 5% in Danish kroner compared to 2012. LEO Pharma's 2013 profit after tax 2012 amounted to 1,175 million DKK against 663 million DKK in 2012.Main EU files targeted
REACH
Incentives ReviewAddress
Head Office
Industriparken, 55
Ballerup 2750
DENMARK -
People
Total lobbyists declared
4
Employment time Lobbyists 75% 2 50% 1 25% 1 Lobbyists (Full time equivalent)
2.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 03 May 2017
Name Start date End Date Ms Katja Murray 03 Mar 2015 27 Feb 2016 Mr Alberto Giummarra 28 Jan 2015 26 Jan 2016 Ms Anne Vibe Balthazar-Christensen 28 Jan 2015 26 Jan 2016 Complementary Information
None declared
Person in charge of EU relations
Ms Alberto Giummarra (Global Public Affairs Manager)
Person with legal responsibility
Ms Gitte Pugholm Aabo (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Member of the The Danish Association of the Pharmaceutical Industry (Lif)
Member of the International Federation of Pharmaceutical Manufactuers & Associations (IFPMA)
Member of EFPIAMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2015 - Jan 2016
Lobbying costs for closed financial year
51,462€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Meetings with MEPs
Danish Pharma events in partnership with the Danish Permanent Representation to the EU
World Psoriasis Day
World Thrombosis DayOther activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 21 May 2021 Location Copenhagen Subject Industrial Strategy Cabinet Cabinet of Executive Vice-President Margrethe Vestager Portfolio Europe Fit for Digital Age Attending - Margrethe Vestager (Executive Vice-President)
Other Lobbyists